Phreesia saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an upgrade from 63 to 71.
IBD's unique RS Rating measures market leadership by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our database.
History shows that the market's biggest winners often have an 80 or better RS Rating as they begin their biggest climbs. See if Phreesia can continue to rebound and clear that threshold.
Can You Really Time The Stock Market?
Phreesia is building a cup without handle with a 26.45 buy point. See if it can break out in volume at least 40% higher than normal.
Phreesia reported 0% EPS growth in its most recent report, while sales growth came in at 17%.
The company earns the No. 8 rank among its peers in the Computer Software-Medical industry group. Doximity, Waystar Holding and Weave Communications are among the top 5 highly rated stocks within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
